Oruka Therapeutics (ORKA) Research & Development (2010 - 2024)
Oruka Therapeutics' Research & Development was $130,000 in Q2 2024, down 48.8% from $254,000 a year earlier and down 21.2% from the prior quarter.
Powered by 
Analysis
Oruka Therapeutics (ORKA) Research & Development (2010 - 2024) Analysis & Trends
On a trailing twelve-month basis, Oruka Therapeutics' Research & Development was $664,000 through Jun 30, 2024, down 61.6% year-over-year; for FY2023, it was $1.01 million, down 78.7% from FY2022.
- Research & Development shows a five-year compound annual growth rate of -24.9% (FY2018 to FY2023).
- In earlier years, Research & Development was $4.75 million in FY2022 (-65.7%), $13.83 million in FY2021 (+177.1%), $4.99 million in FY2020 (+172.3%) and $1.83 million in FY2019 (-56.8%).
- Quarterly Research & Development has moved between $47,000 (Q4 2023) and $3.94 million (Q4 2021) over five years.
- Compared with a year earlier, Research & Development has declined for ten straight quarters, with an average decline of 66.5% over the last eight quarters.
- The best year-over-year quarter for Research & Development over five years was Q2 2021 (growth of 861.6%); the worst was Q4 2022 (a decline of 98.5%).
- Per Business Quant data, ORKA's Research & Development in the three quarters before Q2 2024 was $165,000 (Q1 2024), $47,000 (Q4 2023) and $322,000 (Q3 2023).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 3.65 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 2.34 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 9.74 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | -2.85 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | -4.05 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 1.87 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 1.76 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 2.81 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 993.80 Mn |
| 10 | Oruka Therapeutics | 5.29 Bn | 3.34 Bn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2024 | 130,000.00 |
| Mar 31, 2024 | 165,000.00 |
| Dec 31, 2023 | 47,000.00 |
| Sep 30, 2023 | 322,000.00 |
| Jun 30, 2023 | 254,000.00 |
| Mar 31, 2023 | 390,000.00 |
| Dec 31, 2022 | 61,000.00 |
| Sep 30, 2022 | 1.02 Mn |
| Jun 30, 2022 | 1.49 Mn |
| Mar 31, 2022 | 2.18 Mn |
| Dec 31, 2021 | 3.94 Mn |
| Sep 30, 2021 | 3.44 Mn |
| Jun 30, 2021 | 3.58 Mn |
| Mar 31, 2021 | 2.88 Mn |
| Dec 31, 2020 | 3.20 Mn |
| Sep 30, 2020 | 1.05 Mn |
| Jun 30, 2020 | 372,000.00 |
| Mar 31, 2020 | 365,000.00 |
| Dec 31, 2019 | 384,000.00 |
| Sep 30, 2019 | 347,000.00 |
API Access
Oruka Therapeutics Research & Development API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=research-and-development&ticker=ORKA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "research-and-development", "ticker": "ORKA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=research-and-development&ticker=ORKA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();